Impact of Electronic Cigarettes, Heated Tobacco Products and Conventional Cigarettes on the Generation of Oxidative Stress and Genetic and Epigenetic Lesions in Human Bronchial Epithelial BEAS-2B Cells.

Nrf2 cytotoxicity e-cigarette genotoxicity heat-not-burn tobacco lung

Journal

Toxics
ISSN: 2305-6304
Titre abrégé: Toxics
Pays: Switzerland
ID NLM: 101639637

Informations de publication

Date de publication:
10 Oct 2023
Historique:
received: 06 09 2023
revised: 05 10 2023
accepted: 05 10 2023
medline: 27 10 2023
pubmed: 27 10 2023
entrez: 27 10 2023
Statut: epublish

Résumé

Electronic cigarettes (e-cig) and heated tobacco products (HTP) are often used as smoking cessation aids, while the harm reduction effects of these alternatives to cigarettes are still the subject of controversial debate, in particular regarding their carcinogenic potential. The objective of this study is to compare the effects of e-cig, HTP and conventional cigarette emissions on the generation of oxidative stress and genetic and epigenetic lesions in human bronchial epithelial BEAS-2B cells. Our results show that HTP were less cytotoxic than conventional cigarettes while e-cig were not substantially cytotoxic in BEAS-2B cells. E-cig had no significant effect on the Nrf2 pathway, whereas HTP and cigarettes increased the binding activity of Nrf2 to antioxidant response elements and the expression of its downstream targets HMOX1 and NQO1. Concordantly, only HTP and cigarettes induced oxidative DNA damage and significantly increased DNA strand breaks and chromosomal aberrations. Neither histone modulations nor global DNA methylation changes were found after acute exposure, regardless of the type of emissions. In conclusion, this study reveals that HTP, unlike e-cig, elicit a biological response very similar to that of cigarettes, but only after a more intensive exposure: both tobacco products induce cytotoxicity, Nrf2-dependent oxidative stress and genetic lesions in human epithelial pulmonary cells. Therefore, the health risk of HTP should not be underestimated and animal studies are required in order to determine the tumorigenic potential of these emerging products.

Identifiants

pubmed: 37888697
pii: toxics11100847
doi: 10.3390/toxics11100847
pmc: PMC10611330
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : French National Cancer Institute
ID : INCa_13648
Organisme : French National Cancer Institute
ID : INCa-IReSP_15748

Références

Regul Toxicol Pharmacol. 2016 Nov 30;81 Suppl 2:S17-S26
pubmed: 27450400
Mutat Res Rev Mutat Res. 2022 Jan-Jun;789:108409
pubmed: 35690412
Mutagenesis. 2007 Jan;22(1):3-4
pubmed: 17158789
Environ Mol Mutagen. 2000;35(3):206-21
pubmed: 10737956
Int J Environ Res Public Health. 2021 Apr 13;18(8):
pubmed: 33924379
Toxicol Rep. 2022 Jun 16;9:1357-1368
pubmed: 36561957
Am J Respir Cell Mol Biol. 2004 Dec;31(6):633-42
pubmed: 15333327
Regul Toxicol Pharmacol. 2016 Nov 30;81 Suppl 2:S27-S47
pubmed: 27720919
Epigenetics. 2020 Aug;15(8):816-829
pubmed: 31996072
Toxicol In Vitro. 2019 Feb;54:391-401
pubmed: 29355593
Arch Toxicol. 2016 Feb;90(2):449-61
pubmed: 25526925
Can J Respir Ther. 2015 Fall;51(4):93-8
pubmed: 26566380
Environ Pollut. 2022 Aug 1;306:119346
pubmed: 35489531
Int J Mol Sci. 2022 May 01;23(9):
pubmed: 35563421
Food Chem Toxicol. 2019 Oct;132:110546
pubmed: 31163219
Int J Environ Res Public Health. 2014 Oct 30;11(11):11325-47
pubmed: 25361047
Am J Respir Crit Care Med. 2006 Jul 1;174(1):41-50
pubmed: 16574938
Cochrane Database Syst Rev. 2022 Jan 6;1:CD013790
pubmed: 34988969
FASEB J. 2001 Apr;15(6):1110-2
pubmed: 11292684
Toxicol In Vitro. 2020 Aug;66:104866
pubmed: 32353510
Toxicol In Vitro. 2023 Feb;86:105510
pubmed: 36372310
J Toxicol Environ Health A. 2017;80(23-24):1321-1330
pubmed: 29048996
Chemosphere. 2020 Jun;249:126153
pubmed: 32058129
Mutat Res. 2003 Jan 10;534(1-2):65-75
pubmed: 12504755
Chemosphere. 2021 Jan;263:127874
pubmed: 33297006
Mutagenesis. 1999 Nov;14(6):569-80
pubmed: 10567032
Function (Oxf). 2021 Apr 23;2(3):zqab022
pubmed: 35330676
J Hazard Mater. 2022 Feb 5;423(Pt B):127246
pubmed: 34844363
Food Chem Toxicol. 2019 Jan;123:501-510
pubmed: 30414959
Toxicol Res. 2018 Oct;34(4):281-290
pubmed: 30370002
Mod Pathol. 2011 Jul;24(7):932-43
pubmed: 21423157
J Hazard Mater. 2021 Jan 5;401:123417
pubmed: 32763707
Oral Oncol. 2016 Jan;52:58-65
pubmed: 26547127
Food Chem Toxicol. 2018 Aug;118:940-952
pubmed: 29879435
Contemp Oncol (Pozn). 2021;25(1):45-52
pubmed: 33911981
Carcinogenesis. 2010 Jan;31(1):27-36
pubmed: 19752007
Int J Environ Res Public Health. 2021 Jun 21;18(12):
pubmed: 34205612
Food Chem Toxicol. 2019 Oct;132:110584
pubmed: 31228600
Toxicol Sci. 2021 Jan 28;179(2):220-228
pubmed: 33226417
Chem Res Toxicol. 2020 Jul 20;33(7):1677-1688
pubmed: 32223225
PLoS One. 2017 May 18;12(5):e0177780
pubmed: 28542301
Tob Use Insights. 2022 Feb 23;15:1179173X221076419
pubmed: 35237081
Toxicol In Vitro. 2017 Dec;45(Pt 3):417-425
pubmed: 28065790
Toxicol Rep. 2020 Aug 15;7:1010-1019
pubmed: 32874925
Toxicol In Vitro. 2016 Oct;36:105-113
pubmed: 27470133
Exp Cell Res. 1988 Mar;175(1):184-91
pubmed: 3345800
Antioxidants (Basel). 2022 Sep 16;11(9):
pubmed: 36139904
Redox Biol. 2021 Nov;47:102150
pubmed: 34601427
Mutagenesis. 2006 May;21(3):185-90
pubmed: 16597659
Int J Mol Sci. 2023 Jan 16;24(2):
pubmed: 36675297
Pharmacol Res. 2022 Aug;182:106315
pubmed: 35724819
Sci Total Environ. 2020 Apr 1;711:134666
pubmed: 31812380
Nicotine Tob Res. 2021 Nov 5;23(12):2127-2134
pubmed: 34036368
J Anal Toxicol. 2017 Oct 1;41(8):670-678
pubmed: 28985322
Sci Total Environ. 2022 Mar 20;813:152667
pubmed: 34963586
J Proteome Res. 2014 Feb 7;13(2):982-96
pubmed: 24283195
Nicotine Tob Res. 2019 Jan 1;21(1):111-118
pubmed: 29319815
Chem Res Toxicol. 2022 Feb 21;35(2):254-264
pubmed: 35077135
Mutat Res Rev Mutat Res. 2021 Jan-Jun;787:108365
pubmed: 34083039

Auteurs

Gianni Zarcone (G)

Univ. Lille, CHU Lille, Institut Pasteur de Lille, ULR 4483, IMPECS-IMPact de l'Environnement Chimique sur la Santé, F-59000 Lille, France.

Marie Lenski (M)

Univ. Lille, CHU Lille, Institut Pasteur de Lille, ULR 4483, IMPECS-IMPact de l'Environnement Chimique sur la Santé, F-59000 Lille, France.

Thomas Martinez (T)

Univ. Lille, CHU Lille, Institut Pasteur de Lille, ULR 4483, IMPECS-IMPact de l'Environnement Chimique sur la Santé, F-59000 Lille, France.

Smaïl Talahari (S)

Univ. Lille, CHU Lille, Institut Pasteur de Lille, ULR 4483, IMPECS-IMPact de l'Environnement Chimique sur la Santé, F-59000 Lille, France.

Ophélie Simonin (O)

Univ. Lille, CHU Lille, Institut Pasteur de Lille, ULR 4483, IMPECS-IMPact de l'Environnement Chimique sur la Santé, F-59000 Lille, France.

Guillaume Garçon (G)

Univ. Lille, CHU Lille, Institut Pasteur de Lille, ULR 4483, IMPECS-IMPact de l'Environnement Chimique sur la Santé, F-59000 Lille, France.

Delphine Allorge (D)

Univ. Lille, CHU Lille, Institut Pasteur de Lille, ULR 4483, IMPECS-IMPact de l'Environnement Chimique sur la Santé, F-59000 Lille, France.

Fabrice Nesslany (F)

Univ. Lille, CHU Lille, Institut Pasteur de Lille, ULR 4483, IMPECS-IMPact de l'Environnement Chimique sur la Santé, F-59000 Lille, France.

Jean-Marc Lo-Guidice (JM)

Univ. Lille, CHU Lille, Institut Pasteur de Lille, ULR 4483, IMPECS-IMPact de l'Environnement Chimique sur la Santé, F-59000 Lille, France.

Anne Platel (A)

Univ. Lille, CHU Lille, Institut Pasteur de Lille, ULR 4483, IMPECS-IMPact de l'Environnement Chimique sur la Santé, F-59000 Lille, France.

Sébastien Anthérieu (S)

Univ. Lille, CHU Lille, Institut Pasteur de Lille, ULR 4483, IMPECS-IMPact de l'Environnement Chimique sur la Santé, F-59000 Lille, France.

Classifications MeSH